Neuromuscular HOMEepAGE
neuromuscular.wustl.edu
/
A–Z

DERMATOMYOPATHIES, IMMUNE

Immune/Antibody
W
View full entry on WUSTL Neuromuscular
antibody/infmyop.htm#DERMATOMYOPATHIES, IMMUNE

Overview

From WUSTL Neuromuscular

MYOPATHIES + SKIN DISORDERS, IMMUNE Dermatomyositis Clinical features Comparative features Laboratory Pathology DM-VP: Description IMPP RIIM Treatment History: Firsts ? 1st Case: 1863 Wagner Archiv der Heilkunde Unverricht: Use of term Batten: Pathology Dermatomyopathy Types Dermatomyopathy with Vascular Pathology Childhood NXP2 RIIM TIF1γ (p155) antibody IMPP Jo-1 antibody positive EJ antibody positive Enterovirus PM-Scl cGvHD Inflammatory myopathy Mi-2 antibody Scleroderma (SSc) Dermatomyopathy: Other Adult Amyopathic Drug-related HSF1 antibody MDA5 antibody Mi-2 antibody negative Malignancy

Related Conditions

Shared genes
DERMATOLOGIC DISORDERS & NEUROMUSCULAR DISEASE
VP
Immune & Inflammatory Myopathies: Neoplasm Associations
VPVAMP
Inflammatory & Immune Myopathies (IIM): Acquired
RNAVAMPINCLUSION
Muscle Fiber Pathology
VPSRPVAMP
Other Muscle Features
VAMPINCLUSIONBCIM

External Resources

WUSTL Neuromuscular
Washington University Disease Center
PubMed
Biomedical Literature
GeneReviews
NCBI Expert-Authored Reviews
Orphanet
Portal for Rare Diseases
NORD
National Organization for Rare Disorders

Data sourced from the Washington University Neuromuscular Disease Center. For clinical use, always refer to primary sources.